BI
CGON icon

BVF Inc’s CG Oncology CGON Stock Holding History

BVF Inc’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-994,596
Closed -$37.5M – 54
2024
Q3 		$37.5M Sell
994,596
-1,423,289
-59% -$49.9M 1.1% 27
2024
Q2 		$76.3M Buy
2,417,885
+533,694
+28% +$18.5M 2.14% 15
2024
Q1 		$82.7M Buy
+1,884,191
New +$77M 2.27% 13

Other funds holding CGON

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc's CGON Position: Q4 2024 in Review

BVF Inc sold out of CG Oncology (CGON) in Q4 2024, closing a stake of 994,596 shares — an estimated $37.5M sold.

BVF Inc first reported a position in CGON in Q1 2024 and held it in 3 quarters. The position peaked at $82.7M in Q1 2024. 140 funds tracked by Wall St. Rank hold CGON as of Q4 2024.

  • BVF Inc reported no remaining CG Oncology position as of Q4 2024 after selling out during the quarter.
  • BVF Inc sold 994,596 CG Oncology shares in Q4 2024, an estimated $37.5M.
  • BVF Inc first reported a position in CG Oncology in Q1 2024 and held it in 3 quarters.
  • BVF Inc's CG Oncology position peaked at $82.7M in Q1 2024.
  • 140 funds tracked by Wall St. Rank held CG Oncology as of Q4 2024.

Based on BVF Inc's 13F filing for Q4 2024, filed 14 Feb 2025.